Parkinson's Disease Management. Part II- Discovery of MAO-B Inhibitors Based on Nitrogen Heterocycles and Analogues

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|20|2116-2130

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.20, 2012-10, pp. : 2116-2130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of MAO-B Inhibitors - Present Status and Future Directions Part I: Oxygen Heterocycles and Analogs

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-09 ,pp. : 907-919

Bentham Science Publishers

Access to resources Recommend Favorite

Psychomotor stimulant effects of β-phenylethylamine in monkeys treated with MAO-B inhibitors

By Bergman J.   Yasar S.   Winger G.  

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 21-30

Springer Publishing Company

Access to resources Recommend Favorite

Tobacco Leaf, Smoke and Smoking, MAO Inhibitors, Parkinson's Disease and Neuroprotection; Are There Links?

By Castagnoli K.   Murugesan T.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 279-291

Elsevier

Access to resources Recommend Favorite

Monoamine Oxidase B Inhibitors in Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 4, 2017-07 ,pp. : 425-439

Bentham Science Publishers

Access to resources Recommend Favorite

A Screening System of Prodrugs Selective for MAO-A or MAO-B

By Matsukawa M.   Hirai T.   Karita S.   Akizawa T.   Pan-Hou H.   Yoshioka M.   Goto G.   Parvez H.   Youdim M.B.H.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 293-302

Elsevier

Access to resources Recommend Favorite